Eloxx Pharmaceuticals Inc (ELOX) up 3.70% pre-market

Eloxx Pharmaceuticals Inc (Eloxx Pharmaceuticals Inc (ELOX) was up Monday morning, with the stock adding 3.70% pre-trade to 1.4.

ELOX’s short-term technical score of 4 indicates that the stock has traded less bullish in the past month than 96% of the stocks in the market. In the biotech industry, which ranks 141st out of 146 industries, stock ranks above 10% of stocks.

Eloxx Pharmaceuticals Inc fell 46.85% over the past month, closing at $ 2.30 on April 19. During this time, the stock has fallen as low as $ 1.35 and as high as $ 2.59. ELOX has an average buy analyst recommendation. The company has an average price target of $ 4.50.

ELOX has an overall score of 34. Find out what that means to you and get the rest of the leaderboard on ELOX!

Eloxx Pharmaceuticals Inc has a Long Term Technical Rank of 0. This means that trading in the last 200 trading days placed the company in the bottom half of the stocks with 100% of the market with a higher score. In the biotechnology industry, number 142 according to this metric, ELOX ranks better than 1% of stocks.

Important dates for investors in ELOX:

-Eloxx Pharmaceuticals Inc is expected to report its results on 8/5/2021. In its last earnings release, the company posted EPS of $ -0.73. – We do not have a fixed dividend date for Eloxx Pharmaceuticals Inc at this time. Click here for the full Eloxx Pharmaceuticals Inc (ELOX) stock quote report.

Source link

About Catherine Sherrill

Check Also

Individual investors represent 42% of the ownership of CSPC Pharmaceutical Group Limited (HKG: 1093), while institutions represent 28%

A look at the shareholders of CSPC Pharmaceutical Group Limited (HKG: 1093) can tell us …

Leave a Reply

Your email address will not be published. Required fields are marked *